Emerald Health Pharmaceuticals

Aviva Systems Biology, Corp, located in San Diego, CA, specializes in providing a wide range of high-quality biological research products, including monoclonal and polyclonal antibodies, ELISA kits, and custom recombinant proteins. Their offerings are designed to support various research areas, such as cancer, immunology, and neuroscience, ensuring that scientists have access to validated tools for their experiments. The company is committed to advancing scientific research through innovation, including high-throughput antibody characterization services and a robust selection of technical resources. With a focus on quality and enhanced validation, Aviva Systems Biology is dedicated to meeting the needs of researchers in academia and industry alike. Generated from the website

Genway Biotech, LLC, based in San Diego, CA, has transitioned to Research Products under Aviva Systems Biology. The company specializes in a wide range of products including antibodies, ELISA kits, and proteins, which can be conveniently ordered by catalog number or product name. In addition to its product offerings, Genway Biotech provides custom services such as protein expression, ELISA development, antibody production, and GMP production manufacturing. The organization maintains ISO 13485 accreditation through its wholly-owned subsidiary, ensuring compliance for the development, validation, and production of antibodies and proteins intended for FDA regulated or CE mark products. Generated from the website

Viking Therapeutics, Inc. is a biotechnology company based in San Diego, CA, focused on developing novel therapeutics for patients with metabolic and endocrine disorders. Their pipeline includes several drug candidates targeting conditions such as obesity, non-alcoholic steatohepatitis (NASH), and rare diseases like X-linked adrenoleukodystrophy (X-ALD). The company's key candidates include VK2735 for obesity disorders, VK2809 for NASH, and VK5211 aimed at hip fracture muscle wasting. Viking Therapeutics is committed to advancing innovative treatments that promise to improve patient outcomes in metabolic health. Generated from the website